Note*: This report requires 5-10 business days to complete.
DelveInsight’s Thyroid Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Thyroid Cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Thyroid Cancer till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Thyroid Cancer market.
• Identifying patient populations in the global “Thyroid Cancermarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Thyroid Cancer therapeutics in each of the markets covered.
• To understand the future market competition in the global Thyroid Cancer therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Thyroid Cancer for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Thyroid Cancer overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Thyroid Cancer Market
• Global Epidemiology of Thyroid Cancer Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Thyroid Cancer Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Thyroid Cancer (2013-2023)
• Table 7: Thyroid Cancer Global Market (USD Millions), (2013-2015)
• Table 8: Thyroid Cancer Global Market (USD Millions), (2016-2023)
• Table 9: Thyroid Cancer US Market (USD Millions), (2013-2015)
• Table 10: Thyroid Cancer US Market (USD Millions), (2016-2023)
• Table 11: Thyroid Cancer Germany Market (USD Millions), (2013-2015)
• Table 12: Thyroid Cancer Germany Market (USD Millions), (2016-2023)
• Table 13: Thyroid Cancer United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Thyroid Cancer United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Thyroid Cancer France Market (USD Millions), (2013-2015)
• Table 16: Thyroid Cancer France Market (USD Millions), (2016-2023)
• Table 17: Thyroid Cancer Italy Market (USD Millions), (2013-2015)
• Table 18: Thyroid Cancer Italy Market (USD Millions), (2016-2023)
• Table 19: Thyroid Cancer Spain Market (USD Millions), (2013-2015)
• Table 20: Thyroid Cancer Spain Market (USD Millions), (2016-2023)
• Table 21: Thyroid Cancer Japan Market (USD Millions), (2013-2015)
• Table 22: Thyroid Cancer Japan Market (USD Millions), (2016-2023)
• Table 23: Thyroid Cancer ROW Market (USD Millions), (2013-2015)
• Table 24: Thyroid Cancer ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Thyroid Cancer Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Thyroid Cancer (2013-2023)
• Figure 3: Thyroid Cancer Global Market (USD Millions), (2013-2015)
• Figure 4: Thyroid Cancer Global Market (USD Millions), (2016-2023)
• Figure 5: Thyroid Cancer US Market (USD Millions), (2013-2015)
• Figure 6: Thyroid Cancer US Market (USD Millions), (2016-2023)
• Figure 7: Thyroid Cancer Germany Market (USD Millions), (2013-2015)
• Figure 8: Thyroid Cancer Germany Market (USD Millions), (2016-2023)
• Figure 9: Thyroid Cancer United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Thyroid Cancer United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Thyroid Cancer France Market (USD Millions), (2013-2015)
• Figure 12: Thyroid Cancer France Market (USD Millions), (2016-2023)
• Figure 13: Thyroid Cancer Italy Market (USD Millions), (2013-2015)
• Figure 14: Thyroid Cancer Italy Market (USD Millions), (2016-2023)
• Figure 15: Thyroid Cancer Spain Market (USD Millions), (2013-2015)
• Figure 16: Thyroid Cancer Spain Market (USD Millions), (2016-2023)
• Figure 17: Thyroid Cancer Japan Market (USD Millions), (2013-2015)
• Figure 18: Thyroid Cancer Japan Market (USD Millions), (2015-2023)
• Figure 19: Thyroid Cancer ROW Market (USD Millions), (2013-2015)
• Figure 20: Thyroid Cancer ROW Market (USD Millions), (2016-2023)
• Advenchen Laboratories LLC
• Ariad Pharmaceuticals Inc.
• Boehringer Ingelheim GmbH
• Celgene Corporation
• Hutchison MediPharma Limited
• Immunomedics Inc.
• Nerviano Medical Sciences S.r.l.
• Novartis AG
• Exelixis Inc.
• Genzyme Corporation
• Ignyta Inc.
• Pfizer Inc.
• Plexxikon Inc.
• Vaccinex Inc.
